Elsevier Health Sciences CEO Brian NairnTo Retire; Michael Hansen, Former CEO Of Harcourt Assessment To Succeed
Elsevier praises Nairn’s leadership; Hansen to run health division of world’s largest provider of scientific, technical and medical information
Philadelphia, PA, 7 May, 2008 - Elsevier, the leading publisher of scientific, technical and medical information, announced today that Brian Nairn, CEO of Elsevier Health Sciences, is retiring from the company. Michael Hansen, the former CEO of Harcourt Assessment Inc., has been appointed to succeed Nairn and will report to Erik Engstrom, Elsevier’s CEO; effective June 9th. Nairn will remain with the company during a transition period.
Erik Engstrom said of Brian’s retirement, “I would like to thank Brian for his dedication to the company during his eight years as CEO of Elsevier Health Sciences. In this time the division has more than doubled in revenue, has consistently outperformed the competition and is executing on an exciting segment-based growth strategy.”
Michael Hansen brings extremely relevant experience to his new role. He recently served as CEO of Harcourt Assessment formerly owned by Reed Elsevier. He was previously with Bertelsmann, as EVP of Operational Excellence. He started his career at The Boston Consulting Group in New York, where he became a Partner and Chairman of the global Media Convergence practice and was a senior member of the firm’s health care practice.
Michael said of the appointment, “I’m very proud to join a company that is so uniquely positioned to improve the quality and performance of healthcare delivery worldwide. Brian has developed a powerful team that is driving a rapid growth program in Elsevier Health Sciences. I am very much looking forward to working with them to build on this record of success.”
Hansen holds a law degree from the University of Bonn in Germany and an MBA from Columbia University in New York.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
+1 212 462 1912